Cargando…
Endothelium, for Example
Endothelial nitric oxide production contributes at many levels to cardiovascular efficiency (considered as tissue perfusion relative to cardiac work). Endothelial dysfunction is found in many conditions, including all known risk factors for atheroma, and is usually generalised, when present, involvi...
Autor principal: | |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Royal College of Physicians of London
1996
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5401369/ https://www.ncbi.nlm.nih.gov/pubmed/8745363 |
_version_ | 1783231032677367808 |
---|---|
author | Henderson, Andrew |
author_facet | Henderson, Andrew |
author_sort | Henderson, Andrew |
collection | PubMed |
description | Endothelial nitric oxide production contributes at many levels to cardiovascular efficiency (considered as tissue perfusion relative to cardiac work). Endothelial dysfunction is found in many conditions, including all known risk factors for atheroma, and is usually generalised, when present, involving microvessels as well as large arteries, impairing cardiovascular efficiency and potentially initiating atheroma. Loss of flow-related dilation is a manifestation of endothelial dysfunction and can be measured non-invasively, thereby providing a potential marker of reversible atherogenic susceptibility. |
format | Online Article Text |
id | pubmed-5401369 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 1996 |
publisher | Royal College of Physicians of London |
record_format | MEDLINE/PubMed |
spelling | pubmed-54013692019-01-22 Endothelium, for Example Henderson, Andrew J R Coll Physicians Lond College Lectures Endothelial nitric oxide production contributes at many levels to cardiovascular efficiency (considered as tissue perfusion relative to cardiac work). Endothelial dysfunction is found in many conditions, including all known risk factors for atheroma, and is usually generalised, when present, involving microvessels as well as large arteries, impairing cardiovascular efficiency and potentially initiating atheroma. Loss of flow-related dilation is a manifestation of endothelial dysfunction and can be measured non-invasively, thereby providing a potential marker of reversible atherogenic susceptibility. Royal College of Physicians of London 1996 /pmc/articles/PMC5401369/ /pubmed/8745363 Text en © Journal of the Royal College of Physicians of London 1996 http://creativecommons.org/licenses/by-nc/4.0/This article is distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/) , which permits non-commercial use and redistribution provided that the original author and source are credited. |
spellingShingle | College Lectures Henderson, Andrew Endothelium, for Example |
title | Endothelium, for Example |
title_full | Endothelium, for Example |
title_fullStr | Endothelium, for Example |
title_full_unstemmed | Endothelium, for Example |
title_short | Endothelium, for Example |
title_sort | endothelium, for example |
topic | College Lectures |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5401369/ https://www.ncbi.nlm.nih.gov/pubmed/8745363 |
work_keys_str_mv | AT hendersonandrew endotheliumforexample |